-
Dihydropyrimidine Dehydrogenase (DPYD) Genetic Testing Before Fluoropyrimidine-Based Adjuvant Chemotherapy for Colorectal Cancer in Qatar: A Cost-Effective Approach
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Economic Evaluation Frameworks for AI-Based Digital Health Technologies Across Four HTA Systems
Sep 9, 2025, 16:22 PM -
Bridging the Uncertainty: Cancer Drugs Fund Entry and Exit Outcomes Over Three Years
Sep 9, 2025, 16:22 PM -
The Clinical and Economic Impact of the Introduction of Emicizumab as Prophylactic Treatment for Hemophilia A Patients in Greece
Sep 9, 2025, 16:22 PM -
What About a Latent Cure Model? Assessing Cure Models’ Performance in Pediatric Acute Lymphoblastic Leukemia Treated With Tisagenlecleucel
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Proton Beam Therapy in the Treatment of Pediatric Medulloblastoma in France
Sep 9, 2025, 16:22 PM -
Care Now, Pay Later (CNPL): Evaluating the Budgetary and Access Implications of a Novel Financing Model for Inclisiran in Atherosclerotic Cardiovascular Disease (ASCVD) Patients in India
Sep 9, 2025, 16:22 PM -
Assessing Public Health and Economic Benefits of Nirsevimab or RSVpreF for Preventing RSV-Related Outcomes in Japanese Infants
Sep 9, 2025, 16:22 PM -
Identifying Factors Associated With Involvement in Healthcare Decisions in Wales
Sep 9, 2025, 16:22 PM -
Identifying Risk Profiles for Early Treatment Discontinuation in Geographic Atrophy Using Machine Learning and SHAP Clustering
Sep 9, 2025, 16:22 PM -
Evaluating the Performance of an Artificial Intelligence A-Powered Tool for Assessing Quality of Published Economic Evaluations: A Comparison With Human Reviewers Using the Drummond Checklist
Sep 9, 2025, 16:22 PM -
Variability in Health Utility Scores in Pancreatic Cancer: Findings From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Burden Of Disease, Healthcare Resource Use and Costs of Respiratory Syncytial Virus Among Adults in Spain in 2021-2023 in the Hospital Setting: A Real-World Retrospective Observational Study of Four Hospitals
Sep 9, 2025, 16:22 PM -
The Landscape of the Use of Artificial Intelligence and Machine Learning (AIMI) Methods in Health Technology Assessment (HTA) Submissions
Sep 9, 2025, 16:22 PM -
US Population-Level Clinical Impact of Lorlatinib Treatment on ALK+ Metastatic Non-Small Cell Lung Cancer Outcomes
Sep 9, 2025, 16:22 PM -
Statistical Analysis of Health Technology Assessment Outcomes in Oncology: An Analysis of Key Clinical Value Drivers in Germany and France
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Sparsentan for the Treatment of Immunoglobulin A Nephropathy in Spain
Sep 9, 2025, 16:22 PM -
Health Halo Effect in Supplement Marketing: A Content Analysis of Medical Claims in Community Pharmacies
Sep 9, 2025, 16:22 PM -
Assessing Patient Access to Psoriasis Treatments in Central, South, and Eastern European Countries: Insights and Disparities?
Sep 9, 2025, 16:22 PM -
Characteristics of Real-World Data Landscape in Spain: A Scoping Review
Sep 9, 2025, 16:22 PM
